This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bismuth Sodium Triglycollamate, Sodium Paraaminobenzoate and the Tocopherols (Vitamin E)

HERMAN H. SAWICKY, M.D.

Arch Derm Syphilol. 1950;61(6):906-908.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS WELL known that up to the present there has not been a uniformly satisfactory treatment for any type of lupus erythematosus. Because of this and because of ignorance pertaining to the etiology of the disease, enthusiastic reports extolling the beneficial effects of one drug or another frequently have appeared in the literature. In the therapy unit of the Skin and Cancer Clinic my associates and I have attempted to evaluate some of these newer remedies.

Bismuth Sodium Triglycollamate ("Bistrimate")¹.—Bismuth is widely employed in the treatment of discoid lupus erythematosus and is generally accepted as a valuable agent in the management of this disease. Each tablet of "bistrimate" contains 410 mg. of bismuth sodium triglycollamate, equivalent to 75 mg. of metallic bismuth. Forty-three patients with discoid lupus erythematosus and 2 persons with subacute disseminated lupus erythematosus were treated with this drug for periods ranging from four . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Dermatology and Syphilology of the New York University Post-Graduate Medical School, Dr. Marion B. Sulzberger, chairman, and the Skin and Cancer Unit of University Hospital.

Footnotes
This paper is the sixth in a "Symposium on Lupus Erythematosus," held at the Bronx Dermatological Society on Dec. 15, 1949.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?